Breaking News Instant updates and real-time market news.

LLY

Eli Lilly

$145.17 /

-0.35 (-0.24%)

16:40
12/02/20
12/02
16:40
12/02/20
16:40

Eli Lilly says updated purchase of LY-CoV555 to boost FY20 EPS view by 25c

The company states: "In 2020, the estimated impact of the updated purchase agreement to the guidance range provided in Lilly's earnings release on October 27, 2020 is approximately $500 million of additional revenue and approximately 25 cents of additional earnings per share." TheFly notes that on October 27th, Eli Lilly affirmed its FY20 EPS view of $7.20-$7.40 and revenue view of $23.7B-$24.2B. The impact from the updated order brings that guidance to $7.45-$7.65 vs. consensus $7.25 and revenue of $24.2B-$24.7B vs. consensus $23.72B.

  • 05

    Dec

  • 08

    Dec

  • 15

    Dec

  • 29

    Jan

LLY Eli Lilly
$145.17 /

-0.35 (-0.24%)

11/20/20 Stifel
Precision BioSciences price target raised to $22 from $21 at Stifel
11/17/20 Mizuho
Eli Lilly price target lowered to $156 from $164 at Mizuho
11/10/20 Bernstein
Eli Lilly initiated with a Market Perform, $150 price target at Bernstein
11/10/20 Bernstein
Eli Lilly initiated with a Market Perform at Bernstein

TODAY'S FREE FLY STORIES

Upgrade
Royal Mail upgraded to Buy from Hold at Deutsche Bank » 05:57
01/20/21
01/20
05:57
01/20/21
05:57
ROYMY

Royal Mail

$0.00 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ROYMY Royal Mail
$0.00 /

+ (+0.00%)

01/08/21 Barclays
Royal Mail price target raised to 350 GBp from 300 GBp at Barclays
01/05/21 Berenberg
Royal Mail upgraded to Hold from Sell at Berenberg
12/01/20 Liberum
Royal Mail upgraded to Hold from Sell at Liberum
11/24/20 UBS
Royal Mail downgraded to Neutral from Buy at UBS
Initiation
Repay Holdings initiated with an Equal Weight at Wells Fargo » 05:56
01/20/21
01/20
05:56
01/20/21
05:56
RPAY

Repay Holdings

$25.11 /

+0.94 (+3.89%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RPAY Repay Holdings
$25.11 /

+0.94 (+3.89%)

RPAY Repay Holdings
$25.11 /

+0.94 (+3.89%)

10/05/20 Morgan Stanley
Repay Holdings initiated with an Equal Weight at Morgan Stanley
09/17/20 Barclays
Repay Holdings initiated with an Overweight at Barclays
08/11/20 Canaccord
Repay Holdings price target raised to $30 from $26 at Canaccord
06/17/20 DA Davidson
Repay Holdings price target raised to $31 from $20 at DA Davidson
RPAY Repay Holdings
$25.11 /

+0.94 (+3.89%)

  • 14
    Jan
  • 10
    Sep
  • 29
    May
Conference/Events
H&R Block management to meet virtually with Oppenheimer » 05:55
01/20/21
01/20
05:55
01/20/21
05:55
HRB

H&R Block

$16.42 /

-0.07 (-0.42%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HRB H&R Block
$16.42 /

-0.07 (-0.42%)

HRB H&R Block
$16.42 /

-0.07 (-0.42%)

10/30/20 BTIG
BTIG thinks those looking to potentially short Square, H&R Block should wait
09/03/20 BMO Capital
H&R Block price target lowered to $17 from $19 at BMO Capital
09/01/20 BTIG
H&R Block's tax season distorted by pandemic, say BTIG
07/15/20 Northcoast
H&R Block upgraded to Buy from Neutral at Northcoast
HRB H&R Block
$16.42 /

-0.07 (-0.42%)

HRB H&R Block
$16.42 /

-0.07 (-0.42%)

HRB H&R Block
$16.42 /

-0.07 (-0.42%)

Conference/Events
Genetron management to meet virtually with BTIG » 05:55
01/20/21
01/20
05:55
01/20/21
05:55
GTH

Genetron

$23.34 /

+3.13 (+15.49%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GTH Genetron
$23.34 /

+3.13 (+15.49%)

GTH Genetron
$23.34 /

+3.13 (+15.49%)

09/30/20 Canaccord
Genetron China opportunity understated with current valuation, says Canaccord
08/03/20 Canaccord
Genetron outlook positive ahead of results, says Canaccord
07/14/20 BTIG
Genetron initiated with a Buy at BTIG
GTH Genetron
$23.34 /

+3.13 (+15.49%)

  • 19
    Jun
GTH Genetron
$23.34 /

+3.13 (+15.49%)

Downgrade
Boralex downgraded to Sector Perform from Outperform at National Bank » 05:53
01/20/21
01/20
05:53
01/20/21
05:53
BRLXF

Boralex

$0.00 /

+ (+0.00%)

National Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BRLXF Boralex
$0.00 /

+ (+0.00%)

01/13/21 CIBC
Boralex price target raised to C$55 from C$43 at CIBC
01/06/21 National Bank
Boralex price target raised to C$50 from C$43 at National Bank
12/01/20 Credit Suisse
Boralex initiated with a Neutral at Credit Suisse
11/25/20 RBC Capital
Boralex price target raised to C$42 from C$40 at RBC Capital
Upgrade
Netflix upgraded to Overweight with $700 price target at Wells Fargo » 05:51
01/20/21
01/20
05:51
01/20/21
05:51
NFLX

Netflix

$501.85 /

+3.9 (+0.78%)

Wells Fargo analyst…

Wells Fargo analyst Steven Cahall upgraded Netflix to Overweight from Equal Weight with a price target of $700, up from $510 following last night's Q4 results. While Q4 net additions of 8.5M beat expectations, the company's operating leverage "really impressed," Cahall tells investors in a research note. Netflix is now "effectively cash sustaining," says the analyst. He believes that with "little to hinder pricing growth," and the subscriber base still expanding, Netflix can afford to "grow cash content spend AND deliver strong operating leverage." He sees the long-term economics "providing a catalyst runway" for Netflix shares.

ShowHide Related Items >><<
NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

05:11 Today Wells Fargo
Netflix upgraded to Overweight from Equal Weight at Wells Fargo
05:01 Today Piper Sandler
Netflix price target raised to $652 from $643 at Piper Sandler
04:52 Today Pivotal Research
Netflix price target raised to $750 from $660 at Pivotal Research
04:41 Today UBS
Netflix upgraded to Buy from Neutral at UBS
NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

Downgrade
Rightmove downgraded to Underperform from Neutral at BofA » 05:47
01/20/21
01/20
05:47
01/20/21
05:47
RTMVY

Rightmove

$0.00 /

+ (+0.00%)

BofA downgraded Rightmove…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RTMVY Rightmove
$0.00 /

+ (+0.00%)

01/12/21 Berenberg
Rightmove price target raised to 440 GBp from 400 GBp at Berenberg
12/15/20 JPMorgan
Rightmove price target lowered to 517 GBp from 542 GBp at JPMorgan
11/27/20 UBS
Rightmove price target raised to 620 GBp from 545 GBp at UBS
09/03/20 Barclays
Rightmove price target raised to 525 GBp from 450 GBp at Barclays
Upgrade
DSM upgraded to Outperform from Neutral at Credit Suisse » 05:47
01/20/21
01/20
05:47
01/20/21
05:47
RDSMY

DSM

$0.00 /

+ (+0.00%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RDSMY DSM
$0.00 /

+ (+0.00%)

01/12/21 Bernstein
DSM downgraded to Underperform from Market Perform at Bernstein
11/19/20 Barclays
DSM price target raised to EUR 160 from EUR 153 at Barclays
11/18/20 Barclays
DSM price target raised to EUR 160 from EUR 153 at Barclays
11/18/20 Berenberg
DSM price target raised to EUR 150 from EUR 135 at Berenberg
Downgrade
ProsiebenSat downgraded to Underperform from Neutral at BofA » 05:47
01/20/21
01/20
05:47
01/20/21
05:47
PBSFY

ProsiebenSat

$0.00 /

+ (+0.00%)

BofA downgraded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PBSFY ProsiebenSat
$0.00 /

+ (+0.00%)

01/12/21 Berenberg
ProsiebenSat price target raised to EUR 14.50 from EUR 13.35 at Berenberg
12/08/20 JPMorgan
ProsiebenSat price target raised to EUR 19.50 from EUR 18 at JPMorgan
11/10/20 Deutsche Bank
ProsiebenSat price target raised to EUR 14 from EUR 12 at Deutsche Bank
11/06/20 Credit Suisse
ProsiebenSat price target raised to EUR 6.50 from EUR 5.80 at Credit Suisse
Downgrade
Beyond Meat downgraded to Neutral from Buy at BTIG » 05:43
01/20/21
01/20
05:43
01/20/21
05:43
BYND

Beyond Meat

$141.70 /

+1.56 (+1.11%)

BTIG analyst Peter Saleh…

BTIG analyst Peter Saleh downgraded Beyond Meat to Neutral from Buy without a price target. The analyst believes growth through the retail channel will not be enough to sustain the company's growth rate and "hefty trading multiple" in 2021. While Saleh continues to believe in the long-term trend toward plant-based meats in the grocery and foodservice channels, he expects restaurant operators will remain focused on throughput over menu innovation, limiting adoption and sales growth through the foodservice channel this year. Further, recent international lockdowns, primarily across Europe, will continue to weigh on new partnerships and sales growth for Beyond Meat until a vaccine is widely available and dining rooms reopen, says the analyst. Shah cites a weaker sales growth outlook, heightened price competition and "elevated valuation" for the downgrade of the shares.

ShowHide Related Items >><<
BYND Beyond Meat
$141.70 /

+1.56 (+1.11%)

BYND Beyond Meat
$141.70 /

+1.56 (+1.11%)

01/19/21 JPMorgan
JPMorgan sees 33% downside in Beyond Meat shares, cuts target to $94
01/06/21
Fly Intel: Top five analyst downgrades
01/06/21 Piper Sandler
Beyond Meat downgraded on lagging momentum, estimate risk at Piper Sandler
01/05/21 Piper Sandler
Beyond Meat downgraded to Neutral from Overweight at Piper Sandler
BYND Beyond Meat
$141.70 /

+1.56 (+1.11%)

BYND Beyond Meat
$141.70 /

+1.56 (+1.11%)

BYND Beyond Meat
$141.70 /

+1.56 (+1.11%)

BYND Beyond Meat
$141.70 /

+1.56 (+1.11%)

Recommendations
General Motors added to US 1 List at BofA  05:42
01/20/21
01/20
05:42
01/20/21
05:42
GM

General Motors

$54.85 /

+4.88 (+9.77%)

 
ShowHide Related Items >><<
GM General Motors
$54.85 /

+4.88 (+9.77%)

GM General Motors
$54.85 /

+4.88 (+9.77%)

01/14/21
Fly Intel: Top five analyst upgrades
01/14/21 Argus
General Motors upgraded to Buy at Argus on business expansion, high margins
01/14/21 Argus
General Motors upgraded to Buy from Hold at Argus
01/13/21
Fly Intel: Top five analyst upgrades
GM General Motors
$54.85 /

+4.88 (+9.77%)

GM General Motors
$54.85 /

+4.88 (+9.77%)

GM General Motors
$54.85 /

+4.88 (+9.77%)

GM General Motors
$54.85 /

+4.88 (+9.77%)

Upgrade
Polaris upgraded to Outperform from Market Perform at BMO Capital » 05:39
01/20/21
01/20
05:39
01/20/21
05:39
PII

Polaris

$113.25 /

+5.25 (+4.86%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PII Polaris
$113.25 /

+5.25 (+4.86%)

PII Polaris
$113.25 /

+5.25 (+4.86%)

01/19/21 Morgan Stanley
Polaris initiated with an Overweight at Morgan Stanley
01/19/21 Wedbush
Polaris price target raised to $126 from $116 at Wedbush
01/05/21 Baird
Polaris added to 2021 Best Idea list at Baird
11/27/20
Citi adds Polaris to 'Value Creators' SMID Focus List, removes Knight-Swift
PII Polaris
$113.25 /

+5.25 (+4.86%)

PII Polaris
$113.25 /

+5.25 (+4.86%)

Downgrade
Standard Chartered downgraded to Neutral from Buy at Citi » 05:37
01/20/21
01/20
05:37
01/20/21
05:37
SCBFF

Standard Chartered

$0.00 /

+ (+0.00%)

Citi analyst Ronit Ghose…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SCBFF Standard Chartered
$0.00 /

+ (+0.00%)

SCBFF Standard Chartered
$0.00 /

+ (+0.00%)

01/11/21 Deutsche Bank
Standard Chartered price target raised to 560 GBp from 480 GBp at Deutsche Bank
01/07/21 Investec
Standard Chartered downgraded to Hold from Buy at Investec
11/25/20 Barclays
Standard Chartered price target raised to 410 GBp from 400 GBp at Barclays
10/20/20 Deutsche Bank
Deutsche Bank opens 'Sell Catalyst Call' on Standard Chartered
SCBFF Standard Chartered
$0.00 /

+ (+0.00%)

Downgrade
Michaels downgraded to Underweight from Equal Weight at Morgan Stanley » 05:35
01/20/21
01/20
05:35
01/20/21
05:35
MIK

Michaels

$16.37 /

-0.12 (-0.73%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MIK Michaels
$16.37 /

-0.12 (-0.73%)

MIK Michaels
$16.37 /

-0.12 (-0.73%)

12/14/20 JPMorgan
Michaels downgraded to Neutral after recent rally at JPMorgan
12/14/20 JPMorgan
Michaels downgraded to Neutral from Overweight at JPMorgan
12/04/20
Fly Intel: Top five analyst upgrades
12/04/20 Morgan Stanley
Morgan Stanley upgrades 'healthier' Michaels to Equal Weight
MIK Michaels
$16.37 /

-0.12 (-0.73%)

MIK Michaels
$16.37 /

-0.12 (-0.73%)

MIK Michaels
$16.37 /

-0.12 (-0.73%)

Upgrade
NuStar Energy upgraded to Neutral from Underweight at JPMorgan » 05:34
01/20/21
01/20
05:34
01/20/21
05:34
NS

NuStar Energy

$15.90 /

-0.03 (-0.19%)

JPMorgan analyst Joseph…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NS NuStar Energy
$15.90 /

-0.03 (-0.19%)

NS NuStar Energy
$15.90 /

-0.03 (-0.19%)

01/15/21 Barclays
NuStar Energy reinstated with an Overweight at Barclays
01/06/21 BofA
NuStar Energy downgraded to Underperform from Neutral at BofA
01/06/21 BofA
NuStar Energy downgraded to Underperform from Neutral at BofA
12/03/20 SMBC Nikko
NuStar Energy initiated with a Neutral at SMBC Nikko
NS NuStar Energy
$15.90 /

-0.03 (-0.19%)

Downgrade
Kroger downgraded to Underweight from Equal Weight at Morgan Stanley » 05:34
01/20/21
01/20
05:34
01/20/21
05:34
KR

Kroger

$33.62 /

-0.08 (-0.24%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KR Kroger
$33.62 /

-0.08 (-0.24%)

KR Kroger
$33.62 /

-0.08 (-0.24%)

01/12/21 BMO Capital
Albertsons downgraded to Market Perform from Outperform at BMO Capital
01/07/21 Barclays
Kroger downgraded to Underweight from Equal Weight at Barclays
12/04/20
Fly Intel: Top five analyst downgrades
12/04/20 R5 Capital
Kroger downgraded to Hold after earnings at R5 Capital
KR Kroger
$33.62 /

-0.08 (-0.24%)

KR Kroger
$33.62 /

-0.08 (-0.24%)

KR Kroger
$33.62 /

-0.08 (-0.24%)

KR Kroger
$33.62 /

-0.08 (-0.24%)

Downgrade
Xenia Hotels downgraded to Underweight from Equal Weight at Morgan Stanley » 05:33
01/20/21
01/20
05:33
01/20/21
05:33
XHR

Xenia Hotels

$16.64 /

+0.245 (+1.49%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XHR Xenia Hotels
$16.64 /

+0.245 (+1.49%)

XHR Xenia Hotels
$16.64 /

+0.245 (+1.49%)

01/12/21
Fly Intel: Top five analyst upgrades
01/12/21 Raymond James
Xenia Hotels upgraded to Outperform on leisure exposure at Raymond James
01/12/21 Raymond James
Xenia Hotels upgraded to Outperform from Market Perform at Raymond James
12/14/20 KeyBanc
Xenia Hotels downgraded to Sector Weight from Overweight at KeyBanc
XHR Xenia Hotels
$16.64 /

+0.245 (+1.49%)

Upgrade
Coloplast upgraded to Hold from Sell at Berenberg » 05:33
01/20/21
01/20
05:33
01/20/21
05:33
CLPBY

Coloplast

$0.00 /

+ (+0.00%)

Berenberg analyst Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLPBY Coloplast
$0.00 /

+ (+0.00%)

01/13/21 Barclays
Coloplast price target lowered to DKK 875 from DKK 895 at Barclays
12/09/20 Morgan Stanley
Coloplast price target raised to DKK 843 from DKK 788 at Morgan Stanley
11/06/20 Morgan Stanley
Coloplast price target lowered to DKK 788 from DKK 822 at Morgan Stanley
11/04/20 JPMorgan
Coloplast price target lowered to DKK 880 from DKK 886 at JPMorgan
Downgrade
Albertsons downgraded to Underweight from Equal Weight at Morgan Stanley » 05:32
01/20/21
01/20
05:32
01/20/21
05:32
ACI

Albertsons

$17.74 /

+0.475 (+2.75%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACI Albertsons
$17.74 /

+0.475 (+2.75%)

ACI Albertsons
$17.74 /

+0.475 (+2.75%)

01/15/21 Tigress Financial
Tigress continues to recommend Albertsons purchases, sees further upside
01/15/21 Northcoast
Albertsons price target raised to $21 after Q3 report at Northcoast
01/12/21 BMO Capital
Albertsons downgraded to Market Perform from Outperform at BMO Capital
01/07/21 Barclays
Albertsons downgraded to Underweight from Equal Weight at Barclays
ACI Albertsons
$17.74 /

+0.475 (+2.75%)

  • 26
    Jun
ACI Albertsons
$17.74 /

+0.475 (+2.75%)

ACI Albertsons
$17.74 /

+0.475 (+2.75%)

ACI Albertsons
$17.74 /

+0.475 (+2.75%)

Hot Stocks
Kiromic BioPharma announces completion, certification of Houston facility » 05:32
01/20/21
01/20
05:32
01/20/21
05:32
KRBP

Kiromic BioPharma

$8.70 /

+0.31 (+3.69%)

Kiromic BioPharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KRBP Kiromic BioPharma
$8.70 /

+0.31 (+3.69%)

  • 16
    Oct
KRBP Kiromic BioPharma
$8.70 /

+0.31 (+3.69%)

Downgrade
Gritstone Oncology downgraded to Underperform from Outperform at Baird » 05:31
01/20/21
01/20
05:31
01/20/21
05:31
GRTS

Gritstone Oncology

$22.47 /

+16.07 (+251.09%)

Baird analyst Madhu Kumar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GRTS Gritstone Oncology
$22.47 /

+16.07 (+251.09%)

GRTS Gritstone Oncology
$22.47 /

+16.07 (+251.09%)

07/14/20 BTIG
Gritstone Oncology price target lowered to $17 from $31 at BTIG
GRTS Gritstone Oncology
$22.47 /

+16.07 (+251.09%)

Upgrade
Signature Aviation upgraded to Hold from Sell at Berenberg » 05:30
01/20/21
01/20
05:30
01/20/21
05:30
BBAVY

Signature Aviation

$0.00 /

+ (+0.00%)

Berenberg analyst Eoghan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BBAVY Signature Aviation
$0.00 /

+ (+0.00%)

11/12/20 Berenberg
Signature Aviation price target raised to 205 GBp from 165 GBp at Berenberg
09/09/20 JPMorgan
Signature Aviation price target lowered to 245 GBp from 267 GBp at JPMorgan
09/09/20 Barclays
Signature Aviation price target raised to 265 GBp from 250 GBp at Barclays
08/26/20 JPMorgan
Signature Aviation downgraded to Neutral from Overweight at JPMorgan
Downgrade
Ambu downgraded to Hold from Buy at DNB Markets » 05:30
01/20/21
01/20
05:30
01/20/21
05:30
AMBBY

Ambu

$0.00 /

+ (+0.00%)

DNB Markets analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMBBY Ambu
$0.00 /

+ (+0.00%)

11/12/20 JPMorgan
Ambu price target lowered to DKK 184 from DKK 192 at JPMorgan
10/15/20 JPMorgan
Ambu price target raised to DKK 192 from DKK 190 at JPMorgan
10/12/20 JPMorgan
JPMorgan backs Neutral on Ambu after chairman resignation
08/28/20 JPMorgan
Ambu price target lowered to DKK 190 from DKK 219 at JPMorgan
Downgrade
GlaxoSmithKline downgraded to Underperform from Neutral at Credit Suisse » 05:29
01/20/21
01/20
05:29
01/20/21
05:29
GSK

GlaxoSmithKline

$38.53 /

+0.07 (+0.18%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GSK GlaxoSmithKline
$38.53 /

+0.07 (+0.18%)

GSK GlaxoSmithKline
$38.53 /

+0.07 (+0.18%)

01/15/21 Deutsche Bank
GlaxoSmithKline initiated with a Hold at Deutsche Bank
12/18/20 H.C. Wainwright
Surface Oncology price target raised to $15 from $11 at H.C. Wainwright
12/08/20 JPMorgan
GlaxoSmithKline price target lowered to 1,500 GBp from 1,650 GBp at JPMorgan
12/03/20
Fly Intel: Top five analyst downgrades
GSK GlaxoSmithKline
$38.53 /

+0.07 (+0.18%)

GSK GlaxoSmithKline
$38.53 /

+0.07 (+0.18%)

GSK GlaxoSmithKline
$38.53 /

+0.07 (+0.18%)

GSK GlaxoSmithKline
$38.53 /

+0.07 (+0.18%)

Hot Stocks
Weis Markets CFO Scott Frost to retire, Michael Lockard to succeed » 05:28
01/20/21
01/20
05:28
01/20/21
05:28
WMK

Weis Markets

$47.52 /

-0.97 (-2.00%)

Weis Markets announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.